Akebia Therapeutics (AKBA) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Akebia Therapeutics (AKBA) over the last 9 years, with Q3 2025 value amounting to $578000.0.
- Akebia Therapeutics' Other Operating Expenses changed N/A to $578000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 34524.5%. This contributed to the annual value of -$524000.0 for FY2023, which is N/A changed from last year.
- As of Q3 2025, Akebia Therapeutics' Other Operating Expenses stood at $578000.0.
- Akebia Therapeutics' Other Operating Expenses' 5-year high stood at $1.0 million during Q4 2021, with a 5-year trough of -$524000.0 in Q2 2023.
- Moreover, its 5-year median value for Other Operating Expenses was $578000.0 (2025), whereas its average is $497727.3.
- Per our database at Business Quant, Akebia Therapeutics' Other Operating Expenses soared by 31428.57% in 2021 and then crashed by 6213.81% in 2023.
- Akebia Therapeutics' Other Operating Expenses (Quarter) stood at $1.0 million in 2021, then crashed by 56.37% to $449000.0 in 2022, then plummeted by 216.7% to -$524000.0 in 2023, then skyrocketed by 166.22% to $347000.0 in 2024, then skyrocketed by 66.57% to $578000.0 in 2025.
- Its last three reported values are $578000.0 in Q3 2025, $580000.0 for Q2 2025, and $387000.0 during Q1 2025.